| Proximal tubule model |
HUVECs, PTECs, HK-2 cells |
dECM, sodium alginate, pluronic |
Extrusion-based |
Bioprinted monolayer and bilayer cell tubules |
Cells bioprinted in different concentric configurations; Function demonstrated |
Resolution above 500 µm; dECM requires source organ |
[20] |
| Proximal tubule model |
HUVECs, renal fibroblast, PTECs |
Thermo-responsive proprietary biomaterial ink |
Extrusion-based (piston-driven) |
Bioprinted cell-laden bioink onto a transwell membrane |
Barrier function demonstrated; Suitable for nephrotoxicity studies |
Layered model not compatible with perfusion |
[24] |
| Proximal tubule model with and without vasculature |
PTECs, GMECs, HUVECs |
Gelatin, fibrin, pluronic |
Extrusion-based |
Printing of fugitive ink filaments Encapsulation with hydrogel Seeding hollow channels after removal of filaments |
Demonstrated function between tubules; Models allow perfusion/long term culture |
Cells not included in the process; Tubule resolution as low as 20 µm but below 200 µm cell seeding is limited |
[22,23,25] |
| Proximal tubule, glomerulus |
Human primary kidney cells |
dECM, gelatin, Hyaluronic acid, glycerol |
Extrusion-based |
Bioprinting of dECM-based bioinks |
Developed bioinks suitable for primary cells; Reabsorption function observed on cells |
dECM requires source organ; Limited functional readout demonstrated |
[29] |
| Kidney tubulointerstitium |
Primary murine epithelial cells, HUVECs |
Alginate, pectin and gelatin |
Extrusion-based (microfluidics core-shell) |
Core-shell constructs with epithelial and endothelial concentrically bioprinted into shell and with a sacrificial gel core |
Multiple configurations in core–shell format |
Limited formation of cellular lumen |
[14] |
| Kidney organoid model for drug testing |
Induced pluripotent stem cell (iPSC)-derived kidney organoids |
Biomaterial ink free |
Extrusion bioprinting (piston-based) |
High-throughput (96-well plate format) platform for organoid maturation and drug screening studies |
Patterning with clear impact on differentiation and maturation of organoids |
Bioprinting conformation limited in thickness; Absence of supporting biomaterials |
[50] |
| Kidney organoid model for disease modelling, toxicity and improved differentiation |
Embryonic or iPSC-derived kidney organoids |
Biomaterial ink free |
Liquid handling dispensing system |
High-throughput organoid platform (96-well plate format) |
Allows high throughput screenings for differentiation, toxicity and disease modeling |
Dispensing approach without patterning control described |
[75] |